Evaluating the Effect of Six Proton Pump Inhibitors on the Antiplatelet Effects of Clopidogrel.

Author: BatesVernice, GengoFran M, PrzespolewskiEugene R, RainkaMichelle, SmithNicholas M, WestphalErica S

Paper Details 
Original Abstract of the Article :
Cytochrome P450 (CYP) enzymes are responsible for the conversion of clopidogrel into its active metabolite and the metabolism of proton pump inhibitors (PPIs), which may also inhibit CYP enzymes. A current Food and Drug Administration advisory suggests avoiding esomeprazole and omeprazole while taki...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.01.011

データ提供:米国国立医学図書館(NLM)

Navigating Drug Interactions: Clopidogrel and Proton Pump Inhibitors

The field of pharmacotherapy often involves navigating complex drug interactions, which can impact patient outcomes. This study investigates the potential interaction between clopidogrel, a commonly used antiplatelet medication, and proton pump inhibitors (PPIs). The study aimed to assess the robustness of the interaction between these drugs, addressing concerns about PPIs potentially compromising clopidogrel's antiplatelet effects.

Understanding the Interaction: Clopidogrel and PPIs

The study provides valuable insights into the interaction between clopidogrel and PPIs. It emphasizes the need for careful consideration of potential drug interactions, especially in situations where there is a risk of compromised efficacy. The findings highlight the importance of ongoing research and clinical vigilance in monitoring drug interactions to ensure optimal patient care.

Ensuring Safety and Effectiveness: Key Considerations

If you are taking clopidogrel, it's crucial to discuss any other medications you are taking with your doctor or pharmacist. Understanding potential drug interactions is essential for optimizing treatment outcomes and minimizing risks. This information empowers patients to actively participate in their healthcare journey, ensuring safe and effective treatment.

Dr.Camel's Conclusion

Imagine a desert with winding paths, each leading to a different destination. Drug interactions are like these paths, some leading to desired outcomes and others potentially leading to complications. This research provides valuable insights into the interaction between clopidogrel and PPIs, helping us navigate these paths with greater caution and ensure a smoother journey towards optimal health.

Date :
  1. Date Completed 2018-08-27
  2. Date Revised 2018-08-27
Further Info :

Pubmed ID

29449127

DOI: Digital Object Identifier

10.1016/j.jstrokecerebrovasdis.2018.01.011

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.